BELLEVUE, WA, Feb. 4 /PRNewswire-FirstCall/ - Oncothyreon Inc. , a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the BIO CEO & Investor Conference in New York at 1:15 p.m. ET / 10:15 a.m. PT on Wednesday, February 13, 2008.
A live audio webcast of Dr. Kirkman’s presentation can be accessed at www.oncothyreon.com under the “News & Events” section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon’s goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
CONTACT: Investor and Media Relations, Contact: Julie Rathbun, Rathbun
Communications, (206) 769-9219, ir@oncothyreon.com
